Lambalot R H, Cane D E, Aparicio J J, Katz L
Department of Chemistry, Brown University, Providence, Rhode Island 02912.
Biochemistry. 1995 Feb 14;34(6):1858-66. doi: 10.1021/bi00006a006.
Hydroxylation of C-12 is one of the final steps in the biosynthesis of erythromycin A (ErA). A point of uncertainty in the erythromycin pathway has been whether the C-12 hydroxylase operates on each of two possible substrates, erythromycin B (ErB) and erythromycin D (ErD). Stassi et al. have cloned the gene, designated eryK, which encodes the P-450 monooxygenase responsible for erythromycin C-12 hydroxylation in Saccharopolyspora erythraea [Stassi, D., Donadio, S., Staver, M. J., & Katz, L. (1993) J. Bacteriol. 175, 182-189]. We report the overproduction of EryK in Escherichia coli as insoluble inclusion bodies; the solubilization, refolding, and reconstitution of active holo-EryK; and kinetic confirmation of a 1200-1900-fold preference of the enzyme for ErD over the alternative C-12 hydroxylase substrate ErB. Our results indicate that ErB is a shunt metabolite in the erythromycin biosynthetic pathway.
C-12的羟基化是红霉素A(ErA)生物合成的最后步骤之一。红霉素生物合成途径中一个不确定的问题是C-12羟化酶是否作用于两种可能的底物,即红霉素B(ErB)和红霉素D(ErD)。斯塔西等人克隆了名为eryK的基因,该基因编码负责红色糖多孢菌中红霉素C-12羟基化的P-450单加氧酶[斯塔西,D.,多纳迪奥,S.,斯塔弗,M. J.,& 卡茨,L.(1993年)《细菌学杂志》175,182 - 189]。我们报道了EryK在大肠杆菌中作为不溶性包涵体过量表达;活性全酶EryK的溶解、重折叠和重组;以及动力学证实该酶对ErD的偏好是替代C-12羟化酶底物ErB的1200 - 1900倍。我们的结果表明,ErB是红霉素生物合成途径中的一种分流代谢物。